Nikko Denka Avecia

Nitto Avecia is a leading contract development and manufacturing organization (CDMO) specializing in oligonucleotide-based therapeutics. The company provides a comprehensive suite of services ranging from pre-clinical development and analytical testing to large-scale commercial cGMP manufacturing. With facilities in Massachusetts, Ohio, and California, Nitto Avecia supports a diverse range of modalities including antisense, siRNA, aptamers, and mRNA. As a subsidiary of Nitto Denko Corporation, it leverages advanced polymer and delivery technologies to enhance the production and efficacy of nucleic acid medicines. The company is recognized as the world's largest manufacturer of therapeutic oligonucleotides by capacity.